StoneWise

StoneWise, founded in 2018, is a technology company that drives new drug research and development using artificial intelligence technology. We aim to bring a new perspective to the pharmaceutical industry through technology and innovation, building a world-leading small molecule innovative drug R&D platform. Leveraging extensive knowledge of the drug R&D industry, innovative data integration methods, and robust software and engineering capabilities, the company has established an integrated technology platform centered on target pocket research, molecular generation, ultra-high-throughput virtual screening, rational design, and drug-likeness optimization, which enhances the efficiency and success rate of multiple key stages in the new drug R&D process from hit compound discovery to preclinical candidate compounds. StoneWise has gathered a group of domestic and international experts and outstanding talents from the pharmaceutical industry, artificial intelligence, internet, and other fields, possessing strong scientific research and product development capabilities. Since its establishment, with a proven business model, solid technical foundation, and a comprehensive team, StoneWise has established extensive connections and cooperation with universities, research institutions, and pharmaceutical companies both domestically and internationally, gaining recognition from several top-tier AI and pharmaceutical investment institutions.